Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 May;48(5):1908-11.
doi: 10.1128/AAC.48.5.1908-1911.2004.

Novel inhalational murine model of invasive pulmonary aspergillosis

Affiliations

Novel inhalational murine model of invasive pulmonary aspergillosis

Donald C Sheppard et al. Antimicrob Agents Chemother. 2004 May.

Abstract

We developed a novel model of invasive aspergillosis (IA) that recapitulates human disease. Mice were immunosuppressed with cyclophosphamide and cortisone acetate and then infected in an aerosol chamber. This procedure reproducibly delivered 1 x 10(3) to 3 x 10(3) conidia to the lungs. Lethal pulmonary IA developed over 2 weeks and was prevented by amphotericin B.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Inhalation infection apparatus. Inset panel depicts the compressed air-driven nebulizer connected to a channel across the top of the chamber. This channel leads to an opening located in the center of the chamber ceiling. Nebulized conidia enter the chamber through this orifice and are dispersed throughout the chamber. A door at the right end of the chamber permits access.
FIG. 2.
FIG. 2.
Duration of leukopenia induced by two doses of cyclophosphamide and cortisone acetate. Data are shown as mean leukocyte counts ± standard deviations. Five mice were sampled at each time point. The X denotes the days of administration of cyclophosphamide and cortisone acetate. WBC, white blood cells.
FIG. 3.
FIG. 3.
Survival of mice infected by inhalation and treated with two doses of immunosuppression. Results are the combination of three independent experiments (total n of 27 for each group). *, P of <0.001 by log-rank test compared with values for uninfected mice. ♦, uninfected mice; ▪, infected mice.
FIG. 4.
FIG. 4.
PAS-stained lung sections of mice infected with A. fumigatus by inhalation. (A) Lung tissue 7 days after inoculation showing a focal lesion of IA with invasion of a neighboring blood vessel indicated by the arrow (×100). (B) Higher magnification (×400) demonstrating complete penetration of the blood vessel wall by hyphae (arrow). (C) Lung tissue 10 days after inoculation (after leukocyte recovery) showing the formation of a parenchymal fungal abscess (×100). (D) Higher magnification (×400) demonstrating abundant hyphae surrounded by leukocytes.
FIG. 5.
FIG. 5.
Survival of mice infected with A. fumigatus and treated with AMB, combined results of two experiments, total n of 20 per group. *, P of <0.001 by log-rank test compared with values for mice receiving 5% dextrose agents. ♦, AMB at 3 mg/kg/day; ▪, vehicle (5% dextrose).

References

    1. Denning, D. W. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23:608-615. - PubMed
    1. Denning, D. W., A. Marinus, J. Cohen, D. Spence, R. Herbrecht, L. Pagano, C. Kibbler, V. Kcrmery, F. Offner, C. Cordonnier, U. Jehn, M. Ellis, L. Collette, R. Sylvester, et al. 1998. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. J. Infect. 37:173-180. - PubMed
    1. Graybill, J. R., R. Bocanegra, L. K. Najvar, M. F. Luther, and D. Loebenberg. 1998. SCH56592 treatment of murine invasive aspergillosis. J. Antimicrob. Chemother. 42:539-542. - PubMed
    1. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23-32. - PubMed
    1. Hayashi, R., N. Kitamoto, Y. Iizawa, T. Ichikawa, K. Itoh, T. Kitazaki, and K. Okonogi. 2002. Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary aspergillosis in neutropenic mice. Antimicrob. Agents Chemother. 46:283-287. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources